Literature DB >> 17324452

Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating.

Christiaan H Vinkers1, Victoria B Risbrough, Mark A Geyer, Sorana Caldwell, Malcolm J Low, Richard L Hauger.   

Abstract

Corticotropin-releasing factor (CRF), a neuropeptide released during stress, has been reported to modulate startle behavior, including reducing the threshold for acoustic startle responding and reducing prepulse inhibition (PPI). The central mechanisms mediating CRF system regulation of startle and PPI are still unclear. Some antipsychotic drugs attenuate CRF-induced deficits in PPI in rats and mice. Here we tested the hypothesis that indirect activation of DA(1)-receptors (D(1)) and DA(2)-receptors (D(2)) contributes to the effects of CRF on PPI. We compared the effect of central administration of h/r-CRF (0.2-0.6 nmol) on PPI in mice with either a D(1) or D(2) receptor null mutation (knockout, KO) or in mice pretreated with D(1) or D(2) receptor antagonists SCH23390 (1 mg/kg) or haloperidol (1 mg/kg). D(1) and D(2) KO mice exhibited no significant differences in their sensitivity to CRF-induced disruptions of PPI. Similarly, neither SCH23390 nor haloperidol pretreatment altered the CRF-induced disruption in PPI, although both increased PPI at baseline. CRF-induced increases in startle also remained unchanged by any of the DA receptor manipulations. These results indicate that neither D(1)- nor D(2)-receptor activation is necessary for CRF to exert its effects on acoustic startle and PPI in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324452      PMCID: PMC1892615          DOI: 10.1016/j.pbb.2007.01.018

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  92 in total

1.  Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder.

Authors:  J D Bremner; J Licinio; A Darnell; J H Krystal; M J Owens; S M Southwick; C B Nemeroff; D S Charney
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

2.  Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results.

Authors:  F X Castellanos; E J Fine; D Kaysen; W L Marsh; J L Rapoport; M Hallett
Journal:  Biol Psychiatry       Date:  1996-01-01       Impact factor: 13.382

3.  Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.

Authors:  L G Kirby; K C Rice; R J Valentino
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

4.  Do D1/D2 interactions regulate prepulse inhibition in rats?

Authors:  F J Wan; N Taaid; N R Swerdlow
Journal:  Neuropsychopharmacology       Date:  1996-04       Impact factor: 7.853

Review 5.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.

Authors:  J N Crawley; J K Belknap; A Collins; J C Crabbe; W Frankel; N Henderson; R J Hitzemann; S C Maxson; L L Miner; A J Silva; J M Wehner; A Wynshaw-Boris; R Paylor
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

6.  Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder.

Authors:  C Grillon; C A Morgan; S M Southwick; M Davis; D S Charney
Journal:  Psychiatry Res       Date:  1996-10-16       Impact factor: 3.222

7.  Psychopharmacology of prepulse inhibition in mice.

Authors:  S C Dulawa; M A Geyer
Journal:  Chin J Physiol       Date:  1996       Impact factor: 1.764

8.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors.

Authors:  J Drago; C R Gerfen; J E Lachowicz; H Steiner; T R Hollon; P E Love; G T Ooi; A Grinberg; E J Lee; S P Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF).

Authors:  Y Lee; J Schulkin; M Davis
Journal:  Brain Res       Date:  1994-12-12       Impact factor: 3.252

10.  Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls.

Authors:  P Chappell; J Leckman; W Goodman; G Bissette; D Pauls; G Anderson; M Riddle; L Scahill; C McDougle; D Cohen
Journal:  Biol Psychiatry       Date:  1996-05-01       Impact factor: 13.382

View more
  9 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.

Authors:  Lisa H Conti
Journal:  Neuropharmacology       Date:  2011-08-02       Impact factor: 5.250

3.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

4.  Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.

Authors:  Jodi E Gresack; Victoria B Risbrough
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-21       Impact factor: 5.176

5.  The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Authors:  Hugo A Tejeda; Vladimir I Chefer; Agustin Zapata; Toni S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

6.  The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.

Authors:  Jane E Sutherland; Linda C Burian; Jonathan Covault; Lisa H Conti
Journal:  Pharmacol Biochem Behav       Date:  2010-08-13       Impact factor: 3.533

Review 7.  Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses.

Authors:  D L Walker; L A Miles; M Davis
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-07-10       Impact factor: 5.067

8.  The role of PKC signaling in CRF-induced modulation of startle.

Authors:  M Toth; J E Gresack; R L Hauger; A L Halberstadt; V B Risbrough
Journal:  Psychopharmacology (Berl)       Date:  2013-05-31       Impact factor: 4.530

9.  CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.

Authors:  T N Douma; M J Millan; D Boulay; G Griebel; P M Verdouw; K G Westphal; B Olivier; L Groenink
Journal:  Psychopharmacology (Berl)       Date:  2013-11-02       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.